Srsf1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| | |
|---|---|
| **Gene Symbol** | SRSF1 |
| **Full Name** | Serine/Arginine Rich Splicing Factor 1 |
| **Chromosomal Location** | 17q22 |
| **NCBI Gene ID** | [6732](https://www.ncbi.nlm.nih.gov/gene/6732) |
| **OMIM ID** | [603364](https://www.omim.org/entry/603364) |
| **Ensembl ID** | ENSG00000136450 |
| **UniProt ID** | [P07919](https://www.uniprot.org/uniprot/P07919) |
| **Associated Diseases** | Amyotrophic Lateral Sclerosis, Neurodegeneration |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
SRSF1 (Serine/Arginine Rich Splicing Factor 1), also known as ASF/SF2, is a member of the serine/arginine (SR) family of splicing factors. It plays a critical role in pre-mRNA splicing by recognizing and binding to sequence-specific splicing enhancers (SSEs) located in exon or intron regions. SRSF1 facilitates the recruitment of the spliceosome machinery and regulates both constitutive and alternative splicing.
Beyond splicing, SRSF1 has been implicated in:
SRSF1 has been implicated in ALS pathogenesis through several mechanisms:
SRSF1 is ubiquitously expressed with high expression in:
The study of Srsf1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.